Patricia Allen, Director at Zenas BioPharma, Inc., holds 19.86K shares in Zenas BioPharma, Inc. (Ticker: ZBIO), holds 0.00 shares in Larimar Therapeutics (Ticker: LRMR), holds 0.00 shares in Deciphera Pharmaceuticals (Ticker: DCPH). Most recently, Patricia Allen Bought ― shares of Zenas BioPharma, Inc. on Feb 13, 2026 for an estimated value of $499.75K.
What is the percentage of profitable transactions made by Patricia Allen?
The percentage of profitable transactions made by Patricia Allen is 50%.
What is the average return per transaction made by Patricia Allen?
The average return per transaction made by Patricia Allen is -6.90%.
What stocks does Patricia Allen hold?
Patricia Allen holds: ZBIO, LRMR, DCPH, KANT, ALNY stocks.
What was Patricia Allen’s latest transaction?
Patricia Allen latest transaction was an Informative Buy of $499.75K.
What was Patricia Allen's most profitable transaction?
Patricia Allen’s most profitable transaction was an Informative Buy of ZBIO stock on February 13, 2026. The return on the trade was 17.80%.
What is Patricia Allen's role in Zenas BioPharma, Inc.?
Patricia Allen's role in Zenas BioPharma, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.